Groves, M D <br/><br/>
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Aug 1999 
 - 127-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(99)00122-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Brain Neoplasms--drug therapy<br/>Bromodeoxyuridine--administration & dosage<br/>Cognition--drug effects<br/>Combined Modality Therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Lomustine--administration & dosage<br/>Male<br/>Middle Aged<br/>Procarbazine--administration & dosage<br/>Radiation-Sensitizing Agents--administration & dosage<br/>Reoperation<br/>Vincristine--administration & dosage